newsfilter
← Latest News
FDA Approved Drugs·

Approval of Bixlenvo, Nda #221104 (Type 4 - New Combination)

Approval Date: 08/27/2026; Drug Name: Bixlenvo, Nda #221104; Active Ingredients: BICTEGRAVIR AND LENACAPAVIR; Company: Gilead Sciences; Submission Status: Approval; Submission Classification: Type 4 - New Combination; Application Number: 221104

Company
GILEAD SCIENCES
Keywords
GILEAD SCIENCES